Statement Of Financial Position [Abstract]

BerGenBio - Filing #2615544

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Non-current assets	1,191,000 NOK	—	—	—	2,332,000 NOK	—	—	—	—	—	—	—
Current assets [abstract]
Cash and cash equivalents	436,646,000 NOK	—	—	—	721,641,000 NOK	—	—	—	253,586,000 NOK	—	—	—
Current assets	449,045,000 NOK	—	—	—	735,869,000 NOK	—	—	—	—	—	—	—
Assets	450,236,000 NOK	—	—	—	738,200,000 NOK	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	8,846,000 NOK	—	—	—	8,726,000 NOK	—	—	—	—	—	—	—
Share premium	335,195,000 NOK	—	—	—	628,231,000 NOK	—	—	—	—	—	—	—
Equity	384,426,000 NOK	40,386,000 NOK	335,195,000 NOK	8,846,000 NOK	670,229,000 NOK	8,726,000 NOK	33,272,000 NOK	628,231,000 NOK	219,754,000 NOK	25,860,000 NOK	187,786,000 NOK	6,108,000 NOK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	942,000 NOK	—	—	—	1,367,000 NOK	—	—	—	—	—	—	—
Current liabilities [abstract]
Current provisions [abstract]
Current provisions	969,000 NOK	—	—	—	6,008,000 NOK	—	—	—	—	—	—	—
Current liabilities	64,868,000 NOK	—	—	—	66,604,000 NOK	—	—	—	—	—	—	—
Liabilities	65,810,000 NOK	—	—	—	67,971,000 NOK	—	—	—	—	—	—	—
Equity and liabilities	450,236,000 NOK	—	—	—	738,200,000 NOK	—	—	—	—	—	—	—